Expression and prognostic significance of CIP2A mRNA in hepatocellular carcinoma and nontumoral liver tissues

Hepatocellular Carcinoma

(2011) Nuh N. Rahbari et al.   ANNALS OF SURGERY

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

(2011) C. M. Lucas et al.   BLOOD

High CIP2A immunoreactivity is an independent prognostic indicator in early-stage tongue cancer

(2011) C Böckelman et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein

(2011) Juan Liu et al.   GYNECOLOGIC ONCOLOGY

CIP2A is over-expressed in acute myeloid leukaemia and associated with HL60 cells proliferation and differentiation

(2011) J. WANG et al.   International Journal of Laboratory Hematology

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma

(2011) Jiliang Qiu et al.   Journal of Translational Medicine

PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect

(2011) I Cristóbal et al.   LEUKEMIA

Oncologic Resection for Malignant Tumors of the Liver

(2010) Shefali Agrawal et al.   ANNALS OF SURGERY

CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

(2010) Qian-Ze Dong et al.   ANNALS OF SURGICAL ONCOLOGY

Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy

(2010) Augusto Villanueva et al.   Annual Review of Medicine

CIP2A expression and localization in oral carcinoma and dysplasia

(2010) Joseph Katz et al.   CANCER BIOLOGY & THERAPY

New Strategies in Hepatocellular Carcinoma: Genomic Prognostic Markers

(2010) A. Villanueva et al.   CLINICAL CANCER RESEARCH

CIP2A increases self-renewal and is linked to Myc in neural progenitor cells

(2010) Laura Kerosuo et al.   DIFFERENTIATION

Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue

(2010) Hua-Xiang Xu et al.   INTERNATIONAL JOURNAL OF CANCER

CIP2A expression is increased in prostate cancer

(2010) Markku H Vaarala et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

CIP2A is overexpressed in esophageal squamous cell carcinoma

(2010) Wei Qu et al.   MEDICAL ONCOLOGY

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

(2010) K-F Chen et al.   ONCOGENE

CIP2A Is Associated with Human Breast Cancer Aggressivity

(2009) C. Come et al.   CLINICAL CANCER RESEARCH

Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation

(2009) Kuen-Feng Chen et al.   JOURNAL OF HEPATOLOGY

MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer

(2009) Anchit Khanna et al.   JNCI-Journal of the National Cancer Institute

Major achievements in hepatocellular carcinoma

(2009) Jordi Bruix et al.   LANCET

CIP2A Is Overexpressed in Gastric Cancer and Its Depletion Leads to Impaired Clonogenicity, Senescence, or Differentiation of Tumor Cells

(2008) W. Li et al.   CLINICAL CANCER RESEARCH

Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis

(2008) M A Silva et al.   GUT

Molecular mechanisms of hepatocellular carcinoma

(2008) Rajagopal N. Aravalli et al.   HEPATOLOGY

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

(2008) Yujin Hoshida et al.   NEW ENGLAND JOURNAL OF MEDICINE